Back to Journals » OncoTargets and Therapy » Volume 14

Long Noncoding RNA DLEU1 Aggravates Glioma Progression via the miR-421/MEF2D Axis [Retraction]

Authors Feng L, He M, Rao M, Diao J, Zhu Y 

Received 31 August 2021

Accepted for publication 31 August 2021

Published 9 September 2021 Volume 2021:14 Pages 4735—4736

DOI https://doi.org/10.2147/OTT.S336970



Feng L, He M, Rao M, Diao J, Zhu Y. Onco Targets Ther. 2019;12:5405–5414.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors initially raised concerns that two of the glioma cell lines (LN229 and A172) reported in the study had been contaminated with HeLa cells. The authors advised that they were unable to provide the original raw data for their study and thus were unable to verify its findings. The authors also advised the study did not have approval from the China-Japan Union Hospital of Jilin University ethical committee prior to commencement. This is despite a statement within the article stating that approval had been given.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.